ETF Home ETF List Shorted Stocks Home About

Portfolio Holdings Detail for ISIN IE00BYXG2H39
Stock Name / FundiShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares IV Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF TickerBTEC(USD) LSE
ETF TickerBTEK(GBP) LSE
ETF Ticker2B70(EUR) F
ETF Ticker2B70.DE(EUR) CXE
ETF TickerBTEC.LS(USD) CXE
ETF TickerBTEK.LS(GBP) CXE
ETF TickerBTEC.L(GBP) LSE
ETF TickerBTEK.L(GBP) LSE

Holdings detail for TECX

Stock NameTectonic Therapeutic, Inc.
TickerTECX(USD) NASDAQ
TYPECommon Stock
CountryUSA

Show aggregate TECX holdings

News associated with TECX

Brokerages Set Tectonic Therapeutic, Inc. (NASDAQ:TECX) PT at $80.29
Tectonic Therapeutic, Inc. (NASDAQ:TECX – Get Free Report) has been given a consensus recommendation of “Buy” by the seven ratings firms that are covering the firm, MarketBeat.com reports. Six equities research analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12-month target […] - 2025-09-19 02:26:46
Tectonic Therapeutic, Inc. (NASDAQ:TECX) Receives $80.33 Average Price Target from Analysts
Tectonic Therapeutic, Inc. (NASDAQ:TECX – Get Free Report) has been given an average rating of “Buy” by the six brokerages that are presently covering the stock, Marketbeat Ratings reports. Five investment analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The average 1-year price […] - 2025-08-25 03:00:56
Wall Street Zen Downgrades Tectonic Therapeutic (NASDAQ:TECX) to Sell
Tectonic Therapeutic (NASDAQ:TECX – Get Free Report) was downgraded by Wall Street Zen from a “hold” rating to a “sell” rating in a report released on Saturday. TECX has been the subject of a number of other reports. Lifesci Capital assumed coverage on shares of Tectonic Therapeutic in a report on Friday, June 6th. They […] - 2025-07-28 04:42:47
Tectonic Therapeutic (NASDAQ:TECX) Coverage Initiated by Analysts at Truist Financial
Research analysts at Truist Financial initiated coverage on shares of Tectonic Therapeutic (NASDAQ:TECX – Get Free Report) in a note issued to investors on Monday, MarketBeat Ratings reports. The brokerage set a “buy” rating and a $64.00 price target on the stock. Truist Financial’s price target indicates a potential upside of 188.03% from the stock’s […] - 2025-07-23 05:10:52
Tectonic Therapeutic (NASDAQ:TECX) Receives Consensus Rating of “Buy” from Analysts
Shares of Tectonic Therapeutic (NASDAQ:TECX – Get Free Report) have been assigned an average recommendation of “Buy” from the eight analysts that are presently covering the stock, MarketBeat Ratings reports. Six analysts have rated the stock with a buy recommendation and two have given a strong buy recommendation to the company. The average 1 year […] - 2025-06-13 03:10:56
Tectonic Therapeutic (NASDAQ:TECX) Coverage Initiated at Raymond James
Analysts at Raymond James initiated coverage on shares of Tectonic Therapeutic (NASDAQ:TECX – Get Free Report) in a report issued on Wednesday, MarketBeat reports. The brokerage set an “outperform” rating and a $76.00 price target on the stock. Raymond James’ target price would suggest a potential upside of 238.68% from the company’s previous close. Other […] - 2025-06-13 02:22:54
Tectonic Therapeutic (NASDAQ:TECX) vs. AlloVir (NASDAQ:ALVR) Head-To-Head Comparison
Tectonic Therapeutic (NASDAQ:TECX – Get Free Report) and AlloVir (NASDAQ:ALVR – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, institutional ownership, dividends, analyst recommendations, profitability, risk and earnings. Earnings & Valuation This table compares Tectonic Therapeutic […] - 2025-06-09 02:52:56
28,793 Shares in Tectonic Therapeutic (NASDAQ:TECX) Purchased by Millennium Management LLC
Millennium Management LLC purchased a new position in Tectonic Therapeutic (NASDAQ:TECX – Free Report) in the fourth quarter, HoldingsChannel reports. The fund purchased 28,793 shares of the company’s stock, valued at approximately $1,329,000. Other institutional investors also recently bought and sold shares of the company. Farallon Capital Management LLC grew its holdings in Tectonic Therapeutic […] - 2025-06-04 04:42:50
Jane Street Group LLC Buys New Holdings in Tectonic Therapeutic (NASDAQ:TECX)
Jane Street Group LLC purchased a new position in shares of Tectonic Therapeutic (NASDAQ:TECX – Free Report) in the 4th quarter, Holdings Channel reports. The firm purchased 29,702 shares of the company’s stock, valued at approximately $1,371,000. Several other institutional investors and hedge funds also recently added to or reduced their stakes in the company. […] - 2025-05-20 04:30:48
Tectonic Therapeutic (NASDAQ:TECX) Shares Acquired by Barclays PLC
Barclays PLC increased its stake in shares of Tectonic Therapeutic (NASDAQ:TECX – Free Report) by 1,008.5% in the 4th quarter, HoldingsChannel reports. The firm owned 15,974 shares of the company’s stock after buying an additional 14,533 shares during the quarter. Barclays PLC’s holdings in Tectonic Therapeutic were worth $737,000 at the end of the most […] - 2025-05-07 04:54:59
Tectonic Therapeutic (NASDAQ:TECX) & Agenus (NASDAQ:AGEN) Head to Head Contrast
Agenus (NASDAQ:AGEN – Get Free Report) and Tectonic Therapeutic (NASDAQ:TECX – Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their earnings, institutional ownership, dividends, profitability, analyst recommendations, risk and valuation. Insider & Institutional Ownership 61.5% of Agenus shares […] - 2025-05-05 03:14:50
Mizuho Begins Coverage on Tectonic Therapeutic (NASDAQ:TECX)
Mizuho initiated coverage on shares of Tectonic Therapeutic (NASDAQ:TECX – Get Free Report) in a report released on Monday, Marketbeat.com reports. The brokerage set an “outperform” rating and a $51.00 price target on the stock. Mizuho’s price target suggests a potential upside of 161.67% from the stock’s previous close. Separately, Wells Fargo & Company reduced […] - 2025-04-23 02:10:52
Tectonic Therapeutic (NASDAQ:TECX) Receives $77.75 Consensus Price Target from Analysts
Shares of Tectonic Therapeutic (NASDAQ:TECX – Get Free Report) have received a consensus recommendation of “Buy” from the seven research firms that are currently covering the firm, MarketBeat.com reports. Six investment analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average 12-month price […] - 2025-04-22 02:20:59
Timothy A. Springer Purchases 87,500 Shares of Tectonic Therapeutic (NASDAQ:TECX) Stock
Tectonic Therapeutic (NASDAQ:TECX – Get Free Report) Director Timothy A. Springer purchased 87,500 shares of Tectonic Therapeutic stock in a transaction dated Monday, April 7th. The shares were bought at an average cost of $17.10 per share, for a total transaction of $1,496,250.00. Following the transaction, the director now directly owns 4,313,558 shares of the […] - 2025-04-11 05:16:50
Wells Fargo & Company Cuts Tectonic Therapeutic (NASDAQ:TECX) Price Target to $101.00
Tectonic Therapeutic (NASDAQ:TECX – Free Report) had its price target reduced by Wells Fargo & Company from $112.00 to $101.00 in a research note issued to investors on Friday,Benzinga reports. They currently have an overweight rating on the stock. Tectonic Therapeutic Price Performance NASDAQ:TECX opened at $21.15 on Friday. The firm has a market capitalization […] - 2025-03-24 03:40:49
Brokerages Set Tectonic Therapeutic (NASDAQ:TECX) Price Target at $80.50
Tectonic Therapeutic (NASDAQ:TECX – Get Free Report) has been assigned a consensus rating of “Buy” from the six analysts that are covering the company, MarketBeat Ratings reports. Five analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The average 12 month price target among […] - 2025-03-05 04:55:11
Tectonic Therapeutic (NASDAQ:TECX) Shares Gap Up Following Insider Buying Activity
Shares of Tectonic Therapeutic (NASDAQ:TECX – Get Free Report) gapped up prior to trading on Monday following insider buying activity. The stock had previously closed at $36.45, but opened at $39.98. Tectonic Therapeutic shares last traded at $38.72, with a volume of 45,380 shares traded. Specifically, CFO Daniel Lochner purchased 4,617 shares of the company’s […] - 2025-02-11 04:08:51
China Universal Asset Management Co. Ltd. Purchases Shares of 3,128 Tectonic Therapeutic (NASDAQ:TECX)
China Universal Asset Management Co. Ltd. purchased a new stake in Tectonic Therapeutic (NASDAQ:TECX – Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 3,128 shares of the company’s stock, valued at approximately $144,000. A number of other large investors […] - 2025-02-04 06:53:02
Wells Fargo & Company Increases Tectonic Therapeutic (NASDAQ:TECX) Price Target to $112.00
Tectonic Therapeutic (NASDAQ:TECX – Free Report) had its price objective raised by Wells Fargo & Company from $79.00 to $112.00 in a research report report published on Friday morning,Benzinga reports. The firm currently has an overweight rating on the stock. Other analysts also recently issued research reports about the stock. Leerink Partners upped their price […] - 2025-02-03 05:02:59

iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) TECX holdings

DateNumber of TECX Shares HeldBase Market Value of TECX SharesLocal Market Value of TECX SharesChange in TECX Shares HeldChange in TECX Base ValueCurrent Price per TECX Share HeldPrevious Price per TECX Share Held
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of TECX by Blackrock for IE00BYXG2H39

Show aggregate share trades of TECX

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-10-06BUY9915.20015.600 15.560USD 1,540 24.26
2025-10-03BUY23115.24015.460 15.438USD 3,566 24.31
2025-10-02BUY3315.25016.410 16.294USD 538 24.36
2025-09-30BUY6615.69016.840 16.725USD 1,104 24.46
2025-09-26BUY6615.20015.850 15.785USD 1,042 24.55
2025-09-25BUY6614.71014.970 14.944USD 986 24.61
2025-09-18BUY3315.64016.170 16.117USD 532 24.71
2025-09-17BUY9915.06016.300 16.176USD 1,601 24.77
2025-09-11SELL-3318.03018.140 18.129USD -598 24.95 Profit of 225 on sale
2025-09-10BUY6617.31018.140 18.057USD 1,192 24.99
2025-09-05SELL-3316.80018.030 17.907USD -591 25.14 Profit of 239 on sale
2025-08-29SELL-9925.54025.940 25.900USD -2,564 25.23 Loss of -66 on sale
2025-08-27BUY6626.56026.640 26.632USD 1,758 25.22
2025-08-26SELL-3325.69025.800 25.789USD -851 25.22 Loss of -19 on sale
2025-08-25BUY3324.57026.570 26.370USD 870 25.23
2025-08-20SELL-12824.08024.540 24.494USD -3,135 25.23 Profit of 94 on sale
2025-08-18BUY6424.71024.820 24.809USD 1,588 25.24
2025-08-08SELL-6422.31022.400 22.391USD -1,433 25.33 Profit of 188 on sale
2025-08-05BUY3222.53022.610 22.602USD 723 25.39
2025-08-01SELL-9620.73021.890 21.774USD -2,090 25.45 Profit of 353 on sale
2025-07-30BUY12822.52023.250 23.177USD 2,967 25.49
2025-07-17SELL-6423.28023.500 23.478USD -1,503 25.70 Profit of 142 on sale
2025-07-11SELL-26422.64022.970 22.937USD -6,055 25.80 Profit of 755 on sale
2025-07-07BUY9920.78021.400 21.338USD 2,112 25.94
2025-07-02BUY1,81521.09021.460 21.423USD 38,883 26.06
2025-06-25BUY6420.35020.750 20.710USD 1,325 26.26
2025-06-20BUY2,60019.81020.580 20.503USD 53,308 26.43
2025-06-11BUY4823.50025.750 25.525USD 1,225 26.75
2025-06-10BUY4825.16025.370 25.349USD 1,217 26.77
2025-06-04SELL-2422.66023.630 23.533USD -565 26.90 Profit of 81 on sale
2025-04-23BUY2419.54021.000 20.854USD 500 29.16
2025-04-10SELL-19216.68017.620 17.526USD -3,365 30.75 Profit of 2,540 on sale
2025-04-08SELL-2414.67017.000 16.767USD -402 31.22 Profit of 347 on sale
2025-04-07SELL-2415.53016.830 16.700USD -401 31.47 Profit of 354 on sale
2025-04-04SELL-12015.62016.550 16.457USD -1,975 31.73 Profit of 1,832 on sale
2025-04-01BUY9616.84018.460 18.298USD 1,757 32.20
2025-03-31SELL-7217.71018.640 18.547USD -1,335 32.45 Profit of 1,001 on sale
2025-03-14SELL-38425.63025.750 25.738USD -9,883 34.97 Profit of 3,546 on sale
2025-03-07SELL-4823.18023.610 23.567USD -1,131 36.36 Profit of 614 on sale
2025-03-04SELL-2423.13023.900 23.823USD -572 37.34 Profit of 324 on sale
2025-02-25BUY4826.61027.640 27.537USD 1,322 39.03
2025-02-19SELL-2431.49031.880 31.841USD -764 40.22 Profit of 201 on sale
2025-02-13BUY6934.42034.700 34.672USD 2,392 41.10
2025-02-12BUY2431.60032.570 32.473USD 779 41.47
2025-02-11BUY9231.87034.560 34.291USD 3,155 41.85
2025-01-17BUY9240.90044.000 43.690USD 4,019 41.57
2025-01-16BUY9242.02042.720 42.650USD 3,924 41.51
2025-01-10SELL-4640.16045.290 44.777USD -2,060 44.48 Loss of -14 on sale
2025-01-08SELL-9243.87046.420 46.165USD -4,247 45.69 Loss of -44 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of TECX

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19170,8200271,71262.9%
2025-09-18185,7370396,98746.8%
2025-09-17148,0550212,41269.7%
2025-09-1689,4640164,77354.3%
2025-09-1567,876091,34774.3%
2025-09-1291,1410160,96256.6%
2025-09-1183,5590297,49828.1%
2025-09-1079,7670153,89551.8%
2025-09-0999,3610214,80646.3%
2025-09-08141,9780226,57362.7%
2025-09-05157,1750314,60050.0%
2025-09-04251,475257705,18735.7%
2025-09-03258,20819,821484,69353.3%
2025-09-02471,65647,1271,101,24942.8%
2025-08-2917,35730028,80860.3%
2025-08-2832,463043,31574.9%
2025-08-2729,534033,98586.9%
2025-08-2616,760021,53577.8%
2025-08-2517,355035,19849.3%
2025-08-2243,892077,44456.7%
2025-08-2152,532082,32063.8%
2025-08-2031,406046,37067.7%
2025-08-1932,521043,26175.2%
2025-08-1839,856052,05576.6%
2025-08-1529,358056,47452.0%
2025-08-14105,0420209,42850.2%
2025-08-1350,5970228,36022.2%
2025-08-1265,854089,78673.3%
2025-08-1155,774088,83862.8%
2025-08-0879,7470204,72939.0%
2025-08-0739,100051,51975.9%
2025-08-0669,04120152,29645.3%
2025-08-0546,025060,39476.2%
2025-08-0424,556035,59169.0%
2025-08-0187,0870222,99639.1%
2025-07-31102,3330114,76289.2%
2025-07-3070,0493275,58292.7%
2025-07-29124,6390134,53292.6%
2025-07-2829,848034,81085.7%
2025-07-2538,702044,44087.1%
2025-07-2459,232094,35362.8%
2025-07-2371,0570107,89765.9%
2025-07-2288,840098,58490.1%
2025-07-2139,293054,60472.0%
2025-07-1820,109030,04366.9%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Copyright Market Footprint Ltd. Privacy Policy